Microsoft faces a paradox: thriving financially, yet undergoing significant layoffs. Satya Nadella acknowledged the "enigma of success" amid tech transformation. The company has cut over 15,000 jobs ...

Get daily business news on the companies, industries, and sectors you want to follow.

Intel is planning significant workforce reductions as part of its broader cost-cutting strategy. The company aims to cut about 15% of its workforce by the end of 2025. This could bring the total ...

ConocoPhillips just got a confidence boost from Advisory Resource Group, which hiked its holdings by 5.6% in Q1, adding 12,172 shares. This move nudges the energy giant into the number-three spot in ...

Intel Corporation (INTC) is currently under the microscope with analysts speculating on its future in AI and chips, largely dependent on its collaboration with TSMC. Loop Capital recently pegged Intel ...

Applied Materials received a fresh dose of Wall Street optimism after Cantor Fitzgerald raised its price target from $200 to $220. Multiple analysts recently adjusted their price targets, reflecting a ...

Southern Copper’s stock has analysts divided, with an average “Reduce” rating despite recent earnings beating expectations. Two analysts slapped it with a sell, three opted for hold, and only one ...

T-Mobile is acquiring U.S. Cellular's wireless operations and certain spectrum assets in a $4.4 billion deal that expands its reach. The purchase brings over 4 million new customers and control of ...

AbbVie scored a courtroom win as an Illinois appellate court dismissed a $63 billion shareholder lawsuit over its 2020 Allergan acquisition. The court ruled the share issuance was exempt under Section ...

UnitedHealth Group's recent stock plunge presents a compelling buy for value seekers. After missing earnings expectations and cutting future guidance, the healthcare giant also faced the exit of its ...

Tesla director Ira Matthew Ehrenpreis recently sold 477,572 shares, pocketing a hefty $170.6 million, trimming his stake by nearly 36%. Tesla’s stock, already under pressure, dipped 2.6% after the ...

Merck faces a looming challenge with the 2028 patent expiration of Keytruda, but it’s not sitting around twiddling test tubes. The company has 20 potential blockbuster drugs in its pipeline worth a ...